BioAtla, Inc. (BCAB) Form 8-K — Oct 19, 2026
$BCABForm 8-KItems 1.01, 1.02, 3.02, 9.01Filed Oct 19, 2026, 9:33 PM ET0001193125-26-425553Original filing
BioAtla entered into a $40.0 million Standby Equity Purchase Agreement with Yorkville (YA II PN, Ltd.) on October 15, 2026, replacing a terminated $15.0 million prior SEPA under which only ~$0.4 million had been drawn.
Key figures
- Deal Value Usd
- $40.0 million
- Gross Proceeds
- $40.0 million commitment (drawn at Company's option over 36 months)
- Term months
- 36
- Commitment fee
- $500,000
- Principal market
- OTCQB
- Prior sepa drawn
- approximately $0.4 million on 48,092 shares
- Shares authorized
- 350000000
- Advance size limit
- 100% of average daily trading volume over prior 5 trading days
- Shares outstanding
- 1668261
- Ownership limitation
- 4.99%
- Prior sepa commitment
- $15.0 million
- Purchase price discount
- 97% of lowest daily VWAP over 3-day pricing period
- Commitment fee warrants issued
- 182110
- Commitment fee warrant exercise price
- $0.0001 per share
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.